Mindblown: a blog about philosophy.

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    By Sriparna Roy and Leroy Leo (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    By Sriparna Roy and Leroy Leo (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    By Sriparna Roy and Leroy Leo (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    By Sriparna Roy and Leroy Leo (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    By Sriparna Roy and Leroy Leo (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish drugmaker Novo Nordisk (NYSE:NVO)’s Wegovy by […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish drugmaker Novo Nordisk (NYSE:NVO)’s Wegovy by […]

  • Catalent sees weight-loss drugs boom driving bookings until FY 2026

    (Reuters) -Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs. The contract drug manufacturer plays a vital role in the production of Danish drugmaker Novo Nordisk (NYSE:NVO)’s Wegovy by […]

  • Contract drugmaker Catalent shows signs of recovery in Q1 revenue beat

    (Reuters) -Catalent beat Wall Street’s estimates for first-quarter revenue on Wednesday, as the contract drug manufacturer showed signs of improvement across its struggling pharmaceuticals and biologics businesses. Shares of the company rose nearly 6% in premarket trade as its adjusted net loss was also smaller than expected, indicating early signs of recovery on the back […]

  • Huawei and Xiaomi drive China’s smartphone market recovery with new launches

    BEIJING – China’s smartphone industry is witnessing a significant rebound, with major domestic brands like Huawei and Xiaomi (OTC:XIACF) reporting robust sales growth. This resurgence comes after an eight-month period of sluggish performance, marking a turning point for the sector. In early October, Huawei Technologies, headquartered in Shenzhen, catalyzed a revival in the market with […]

Got any book recommendations?


RocketplayRocketplay casinoCasibom GirişJojobet GirişCasibom Giriş GüncelCasibom Giriş AdresiCandySpinzDafabet AppJeetwinRedbet SverigeViggoslotsCrazyBuzzer casinoCasibomJettbetKmsauto DownloadKmspico ActivatorSweet BonanzaCrazy TimeCrazy Time AppPlinko AppSugar rush